Cambridge Cognition Holdings Plc (LON:COG – Get Free Report)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 36.22 and traded as low as GBX 31. Cambridge Cognition shares last traded at GBX 31, with a volume of 12,181 shares trading hands.
Cambridge Cognition Stock Performance
The stock has a fifty day moving average price of GBX 33.31 and a two-hundred day moving average price of GBX 36.22. The company has a market cap of £16.73 million, a P/E ratio of -7.95 and a beta of 0.81. The company has a debt-to-equity ratio of 29.16, a current ratio of 0.40 and a quick ratio of 0.96.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Featured Stories
- Five stocks we like better than Cambridge Cognition
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
- 3 Low-P/E Stocks That Look Cheap as the S&P 500 Trades Near Record Highs
- Travel + Leisure Goes Big—Is It Ready to Rally?
- 2 Biotech Stocks Shaping Up for Major Breakouts
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
